Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ATNF is 0.49M, and currently, short sellers hold a 16.05% ratio of that floaft. The average trading volume of ATNF on October 31, 2024 was 1.93M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ATNF) stock’s latest price update
The stock price of 180 Life Sciences Corp (NASDAQ: ATNF) has dropped by -11.29 compared to previous close of 4.43. Despite this, the company has seen a fall of -7.53% in its stock price over the last five trading days. accesswire.com reported 2024-10-29 that PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. (“180” or the “Company”) (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective immediately.
ATNF’s Market Performance
ATNF’s stock has fallen by -7.53% in the past week, with a monthly rise of 155.19% and a quarterly rise of 87.14%. The volatility ratio for the week is 19.21% while the volatility levels for the last 30 days are 26.76% for 180 Life Sciences Corp The simple moving average for the past 20 days is 25.30% for ATNF’s stock, with a 60.11% simple moving average for the past 200 days.
Analysts’ Opinion of ATNF
Many brokerage firms have already submitted their reports for ATNF stocks, with Maxim Group repeating the rating for ATNF by listing it as a “Buy.” The predicted price for ATNF in the upcoming period, according to Maxim Group is $11 based on the research report published on September 15, 2021 of the previous year 2021.
ATNF Trading at 65.11% from the 50-Day Moving Average
After a stumble in the market that brought ATNF to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.86% of loss for the given period.
Volatility was left at 26.76%, however, over the last 30 days, the volatility rate increased by 19.21%, as shares surge +178.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +111.29% upper at present.
During the last 5 trading sessions, ATNF fell by -7.53%, which changed the moving average for the period of 200-days by +3.42% in comparison to the 20-day moving average, which settled at $3.14. In addition, 180 Life Sciences Corp saw -3.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ATNF starting from Feldmann Marc, who sale 25,000 shares at the price of $0.19 back on Dec 15 ’23. After this action, Feldmann Marc now owns 115,497 shares of 180 Life Sciences Corp, valued at $4,700 using the latest closing price.
Woody James N., the Chief Executive Officer of 180 Life Sciences Corp, purchase 25,000 shares at $0.19 during a trade that took place back on Dec 15 ’23, which means that Woody James N. is holding 66,888 shares at $4,700 based on the most recent closing price.
Stock Fundamentals for ATNF
Current profitability levels for the company are sitting at:
- -53.78 for the present operating margin
- 0.38 for the gross margin
The net margin for 180 Life Sciences Corp stands at -75.59. The total capital return value is set at 85.3. Equity return is now at value -398.58, with -142.80 for asset returns.
Based on 180 Life Sciences Corp (ATNF), the company’s capital structure generated 18.2 points at debt to capital in total, while cash flow to debt ratio is standing at -9.59. The debt to equity ratio resting at -1.06. The interest coverage ratio of the stock is -180.49.
Currently, EBITDA for the company is -13.37 million with net debt to EBITDA at 0.08. When we switch over and look at the enterprise to sales, we see a ratio of 3.22. The receivables turnover for the company is 16.67for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.58.
Conclusion
In a nutshell, 180 Life Sciences Corp (ATNF) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
